Your browser doesn't support javascript.
loading
Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America.
Balderramo, Domingo; Quaresma, Abel Botelho; Olivera, Pablo A; Savio, Mariane Christina; Villamil, Maria Paz Gimenez; Panaccione, Remo; Ng, Siew C; Kaplan, Gilaad G; Kotze, Paulo Gustavo.
Afiliação
  • Balderramo D; Gastroenterology Department, Hospital Privado Universitario de Córdoba, Instituto Universitario de Ciencias Biomédicas de Córdoba, Córdoba, Argentina.
  • Quaresma AB; Health Sciences Postgraduate Program, Pontificia Universidade Católica do Paraná, Curitiba, Brazil; IBD Outpatient Clinic, Universidade do Oeste de Santa Catarina, Joaçaba, Brazil. Electronic address: abel@proctoclinic.com.br.
  • Olivera PA; Inflammatory Bowel Disease Unit, Gastroenterology Section, Department of Internal Medicine, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina; Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada; Divi
  • Savio MC; Health Sciences Postgraduate Program, Pontificia Universidade Católica do Paraná, Curitiba, Brazil.
  • Villamil MPG; Health Sciences Postgraduate Program, Pontificia Universidade Católica do Paraná, Curitiba, Brazil.
  • Panaccione R; Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
  • Ng SC; Department of Medicine and Therapeutics, Institute of Digestive Disease, LKS institute of Health Science, the Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Kaplan GG; Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada.
  • Kotze PG; Health Sciences Postgraduate Program, Pontificia Universidade Católica do Paraná, Curitiba, Brazil.
Lancet Gastroenterol Hepatol ; 9(3): 263-272, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38340754
ABSTRACT
The incidence and prevalence of inflammatory bowel disease (IBD), namely Crohn's disease and ulcerative colitis, have increased in Latin America over the past few decades. Although incidence is accelerating in some countries in the region, other areas in Latin America are already transitioning into the next epidemiological stage-ie, compounding prevalence-with a similar epidemiological profile to the western world. Consequently, more attention must be given to the diagnosis and management of IBD in Latin America. In this Review, we provide an overview of epidemiology, potential local environmental risk factors, challenges in the management of IBD, and limitations due to the heterogenity of health-care systems, both public and private, in Latin America. Unresolved issues in the region include inadequate access to diagnostic resources, biological therapies, tight disease monitoring (including treat to target therapy, surveillance and prevention of complications, drug monitoring), and specialised IBD surgery. Local guidelines are an important effort to overcome barriers in IBD management. Advancements in long-term health-care policies will be important to promote early diagnosis, access to new treatments, and improvements in research in Latin America. These improvements will not only affect overall health care but will also lead to optimal prioritisation of IBD-related costs and resources and enhance the quality of life of people with IBD in Latin America.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article